Discounted biosimilar prices will continue to have a significant impact on overall biosimilar sales, as patients will continue to be the primary beneficiaries. Innovator price drops with steep discounts are a recent and ongoing trend among manufacturers in developing biosimilar markets. This will continue to be a popular trend throughout the forecast period, eventually propelling the global Biosimilars Market growth. Furthermore, biosimilar manufacturers are likely to test multiple production volumes or different scales of production. During the forecast period, the potential profitability of manufacturing multiple biosimilar products in the same facility may also be a favorable growth opportunity for biosimilar manufacturing companies.